Atlas Trials

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects

Clinical trial NCT02294851 · COMPLETED

Trial details

NCT number
NCT02294851
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tauopathies
Start date
2014-12-31
Primary completion
2016-04-30
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.